-40%
ISIS Pharma Metroruboril A.Z. Anti-Redness & Rosacea Cream 30ml. Severe redness
ISIS Pharma Metroruboril A.Z. Anti-Redness & Rosacea Cream 30ml. Severe redness
ISIS Pharma Metroruboril A.Z. Anti-Redness & Rosacea Cream 30ml. Severe redness

ISIS Pharma Metroruboril A.Z. Anti-Redness & Rosacea Cream 30ml. Severe redness

€ 10.47

Availability: 37 in stock
  • All returns accepted: Returns Accepted
  • Department: Unisex
  • Size: 30ml
  • Item must be returned within: 30 Days
  • Type: Day Treatment
  • Body Area: Face
  • Country/Region of Manufacture: France
  • Tinted: No
  • Skin Type: All Skin Types
  • Restocking Fee: No
  • Brand: ISIS Pharma
  • Condition: New
  • Refund will be given as: Money Back
  • Formulation: Cream
  • Return shipping will be paid by: Seller
  • Main Purpose: Redness

    Description

    ISIS PHARMA METRORUBORIL A.Z.
    ANTI-REDNESS & ROSACEA CREAM 30ML
    INDICATIONS
    Redness and rosacea
    Anti-redness and rosacea care
    PROPERTIES
    1 Reduces redness within 4 weeks
    2 Reduces inflammatory lesions (papules and pustules)
    3 Improves cutaneous microcirculation
    4 Hydrates and soothes
    INGREDIENTS
    Azelaic acid (15%)  Antibacterial / Antimicrobial / Anti-inflammatory
    ß-calm® complex  Anti-redness / Soothing / Fortifying / Moisturising
    Glycerin (2%)  Moisturising agent
    USE
    Morning and evening to clean skin.
    0% Paraben . 0% Phenoxyethanol . Alcohol-free . Fragrance free
    TESTED UNDER DERMATOLOGICAL CONTROL
    CLINICALLY PROVEN EFFICACY
    PROTOCOL
    . Study carried out on 20 subjects presenting papulopustular rosacea on the face.
    . Application: twice a day during 56 days.
    . Clinical examination of the cutaneous state of the face by the dermatologist in charge of the study and counting of the inflammatory lesions.
    . Measurement of cutaneous color using Spectrocolorimeter®.
    . Measurement of the cutaneous microcirculation using TiVi600® on the face.
    . Photography of the full face using Visia®.
    CLINICAL RESULTS
    D0 D56 D0 D56
    • Decrease in inflammatory lesions
    Papules -45% at Day 28 -60% at Day 56
    Pustules -59% at Day 28 -88% at Day 56
    • Decrease in redness
    -17% at Day 28 -18% at Day 56